P0768 : Late mortality in treatment-experienced cirrhotic patients treated with triple therapy including boceprevir or telaprevir in a real-life cohort - ANRS Co 20 cupic - Université de Rennes Access content directly
Conference Poster Year : 2015

P0768 : Late mortality in treatment-experienced cirrhotic patients treated with triple therapy including boceprevir or telaprevir in a real-life cohort - ANRS Co 20 cupic

J. -P. Bronowicki
  • Function : Author
D. Larrey
  • Function : Author
V. Canva
  • Function : Author
V. de Ledinghen
  • Function : Author
Laurent Alric
  • Function : Author
  • PersonId : 881462
J. -P. Zarski
  • Function : Author
J. -J. Raabe
  • Function : Author
S. Metivier
  • Function : Author
G. Riachi
  • Function : Author
A. Abergel
V. Loustaud-Ratti
  • Function : Author
X. Causse
  • Function : Author
P. -H. Bernard
  • Function : Author
P. Attali
  • Function : Author
V. Di Martino
  • Function : Author
I. Rosa
  • Function : Author
V. Grando-Lemaire
  • Function : Author
I. Portal
  • Function : Author
T. Dao
  • Function : Author
D. Lucidarme
  • Function : Author
T. Fontanges
  • Function : Author
J. -M. Pawlotsky
  • Function : Author
C Hezode
  • Function : Author

Abstract

no abstract
No file

Dates and versions

hal-01162777 , version 1 (11-06-2015)

Identifiers

Cite

J. -P. Bronowicki, H. Fontaine, C. Dufour, F. Zoulim, D. Larrey, et al.. P0768 : Late mortality in treatment-experienced cirrhotic patients treated with triple therapy including boceprevir or telaprevir in a real-life cohort - ANRS Co 20 cupic. The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S617--S618, 2015, ⟨10.1016/S0168-8278(15)30971-5⟩. ⟨hal-01162777⟩
443 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More